News & Industry Bulletins

Wednesday, October 3, 2012

Dominion Diagnostics launches new clinically relevant testing profile for bath salts detection

Leading national drug testing and medication monitoring company Dominion Diagnostics has launched new, more sensitive, and more relevant testing to detect synthetic cathinones or “bath salts” in urine.  Designed by Dominion’s Research and Development team, the test will detect five synthetic cathinones:  mephedrone, 3,4-methylendioxypyrovalerone (MDPV), methylone, butylone, and ethylone.   The testing, performed by liquid c

Wednesday, May 30, 2012

Dominion Diagnostics to Host a Free Continuing Education Symposium for Addiction Treatment Professionals on June 13, 2012 in San Francisco, California

A free, one-day continuing education symposium for addiction treatment professionals, “Treatment, Intervention & Innovation:  Challenges and Solutions in the Addiction Field Today”, will be held at the Mission Bay Conference Center at the University of California San Francisco at 1675 Owens Street in San Francisco on Wednesday, June 13, 2012.  The program is scheduled from 8:30 a.m. to 5:00 p.m.

Tuesday, February 21, 2012

Dominion Diagnostics Celebrates 15 Years in Drug Monitoring, Clinical Support, and Education

Dominion Diagnostics, LLC, a leading national medication and substance use monitoring company, is celebrating its fifteenth year in business providing quality monitoring services, clinical support and education to improve patient outcomes in addiction treatment and pain management.

Pages